Detalles de la búsqueda
1.
Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
Cancer Sci;
111(7): 2508-2525, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415868
2.
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
Int J Cancer;
145(7): 1838-1851, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30882895
3.
Examination of HER3 targeting in cancer using monoclonal antibodies.
Proc Natl Acad Sci U S A;
112(3): 839-44, 2015 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25564668
4.
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.
Proc Natl Acad Sci U S A;
110(5): 1815-20, 2013 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23319610
5.
Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies.
J Biol Chem;
286(13): 11337-45, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21282108
6.
[The HER3/ERBB3 receptor: the dark side of the ERBB planet]. / Le récepteur HER3 ou ERBB3 - La face cachée de la planète ERBB.
Med Sci (Paris);
31(5): 465-8, 2015 May.
Artículo
en Francés
| MEDLINE | ID: mdl-26059291
7.
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor.
Cancers (Basel);
12(9)2020 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847130
8.
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
MAbs;
11(3): 593-605, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30604643
9.
Local induction of heat shock protein 70 (Hsp70) by proteasome inhibition confers chondroprotection during surgically induced osteoarthritis in the rat knee.
Biomed Mater Eng;
18(4-5): 253-60, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19065031
10.
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Cancer Lett;
432: 227-236, 2018 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29935372
11.
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.
EMBO Mol Med;
10(2): 294-308, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29212784
12.
Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis.
FASEB J;
20(1): 65-75, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16394269
13.
CRISPR-assisted receptor deletion reveals distinct roles for ERBB2 and ERBB3 in skin keratinocytes.
FEBS J;
284(19): 3339-3349, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28805349
14.
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.
Hum Vaccin Immunother;
12(3): 576-92, 2016 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26529100
15.
Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer.
Sci Signal;
8(379): ra53, 2015 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26038598
16.
ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.
Cancer Res;
75(17): 3554-67, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26206558
17.
Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo.
Biorheology;
41(3-4): 521-34, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15299283
18.
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.
Oncotarget;
5(16): 7138-48, 2014 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25216528
19.
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.
Neoplasia;
15(3): 335-47, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23479511
20.
In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
Neoplasia;
14(2): 121-30, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22431920